364 related articles for article (PubMed ID: 22524574)
21. The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma.
Qu XD; Chen CS; Wang JH; Yan ZP; Chen JM; Gong GQ; Liu QX; Luo JJ; Liu LX; Liu R; Qian S
BMC Cancer; 2012 Jun; 12():263. PubMed ID: 22721173
[TBL] [Abstract][Full Text] [Related]
22. Is it time to adopt external beam radiotherapy in the NCCN guidelines as a therapeutic strategy for intermediate/advanced hepatocellular carcinoma?
Jiang W; Zeng ZC
Oncology; 2013; 84 Suppl 1():69-74. PubMed ID: 23428862
[TBL] [Abstract][Full Text] [Related]
23. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
[TBL] [Abstract][Full Text] [Related]
24. Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study.
Sieghart W; Pinter M; Reisegger M; Müller C; Ba-Ssalamah A; Lammer J; Peck-Radosavljevic M
Eur Radiol; 2012 Jun; 22(6):1214-23. PubMed ID: 22215073
[TBL] [Abstract][Full Text] [Related]
25. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.
Burrel M; Reig M; Forner A; Barrufet M; de Lope CR; Tremosini S; Ayuso C; Llovet JM; Real MI; Bruix J
J Hepatol; 2012 Jun; 56(6):1330-5. PubMed ID: 22314428
[TBL] [Abstract][Full Text] [Related]
26. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
Lencioni R; Chen XP; Dagher L; Venook AP
Oncologist; 2010; 15 Suppl 4():42-52. PubMed ID: 21115580
[TBL] [Abstract][Full Text] [Related]
27. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL
Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
[TBL] [Abstract][Full Text] [Related]
28. Sequential therapy of transarterial chemoembolisation and sorafenib in intermediate stage hepatocellular carcinoma.
Welker MW; Zangos S; Kriener S; Mönch C; Zeuzem S; Trojan J
J Gastrointest Cancer; 2010 Jun; 41(2):149-52. PubMed ID: 20396977
[TBL] [Abstract][Full Text] [Related]
29. Open-Label Single-Arm Phase II Trial of Sorafenib Therapy with Drug-eluting Bead Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma: Clinical Results.
Cosgrove DP; Reyes DK; Pawlik TM; Feng AL; Kamel IR; Geschwind JF
Radiology; 2015 Nov; 277(2):594-603. PubMed ID: 26069923
[TBL] [Abstract][Full Text] [Related]
30. Closing remarks.
Kudo M
Clin Drug Investig; 2012 Aug; 32 Suppl 2():52. PubMed ID: 22873627
[No Abstract] [Full Text] [Related]
31. Survival of patients with advanced hepatocellular carcinoma: sorafenib versus other treatments.
Kim HY; Park JW; Nam BH; Kim HK; Choi JI; Kim TH; Kim HB; Kim CM
J Gastroenterol Hepatol; 2011 Nov; 26(11):1612-8. PubMed ID: 21517968
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of sorafenib in intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization.
Ogasawara S; Chiba T; Ooka Y; Kanogawa N; Motoyama T; Suzuki E; Tawada A; Kanai F; Yoshikawa M; Yokosuka O
Oncology; 2014; 87(6):330-41. PubMed ID: 25227534
[TBL] [Abstract][Full Text] [Related]
33. Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis.
Park MS; Kim SU; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Seong J
Cancer Chemother Pharmacol; 2013 Jan; 71(1):165-73. PubMed ID: 23079897
[TBL] [Abstract][Full Text] [Related]
34. Regression of hepatocellular carcinoma with right atrial extension after sorafenib and transarterial chemoembolization.
Subramanian M; Singal AG; Yopp AC
Clin Gastroenterol Hepatol; 2012 Oct; 10(10):e83-4. PubMed ID: 22813441
[No Abstract] [Full Text] [Related]
35. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
[TBL] [Abstract][Full Text] [Related]
36. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.
Kim JH; Yoon HK; Kim SY; Kim KM; Ko GY; Gwon DI; Sung KB
Aliment Pharmacol Ther; 2009 Jun; 29(12):1291-8. PubMed ID: 19392861
[TBL] [Abstract][Full Text] [Related]
37. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
[TBL] [Abstract][Full Text] [Related]
38. Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma.
Seki A; Hori S
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):555-62. PubMed ID: 21562932
[TBL] [Abstract][Full Text] [Related]
39. The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trial.
Chao Y; Chung YH; Han G; Yoon JH; Yang J; Wang J; Shao GL; Kim BI; Lee TY
Int J Cancer; 2015 Mar; 136(6):1458-67. PubMed ID: 25099027
[TBL] [Abstract][Full Text] [Related]
40. Safety and effectiveness of chemoembolization with drug-eluting beads for advanced-stage hepatocellular carcinoma.
Kalva SP; Pectasides M; Liu R; Rachamreddy N; Surakanti S; Yeddula K; Ganguli S; Wicky S; Blaszkowsky LS; Zhu AX
Cardiovasc Intervent Radiol; 2014 Apr; 37(2):381-7. PubMed ID: 23754191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]